Gabapentin Capsule
Product Images NDC 71205-619

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gaba-fig-1-jpg.jpg (Gaba Fig 1 Jpg)

A line graph depicting mean pain scores over an 8-week period comparing Gabapentin 3600 mg/day to placebo. The x-axis shows weeks from baseline to 8, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin shows a declining pain score trend, while placebo remains relatively constant.*

FDA Label Image

Gaba-fig-2-jpg.jpg (Gaba Fig 2 Jpg)

Line graph showing mean pain scores over seven weeks comparing placebo and gabapentin doses of 1800 mg/day and 2400 mg/day. The x-axis represents weeks, divided into a 3-week dose titration period and a 4-week fixed dose period. The y-axis measures mean pain score from 0 to 10. Gabapentin treatments show a decrease in pain scores over time compared to placebo.*

FDA Label Image

Gaba-fig-3-jpg.jpg (Gaba Fig 3 Jpg)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) doses in two studies. Study 1 shows 12% response for placebo and 29% for GBP 3600 mg. Study 2 shows 14% for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance indicators include p < 0.01 and p < 0.001.*

FDA Label Image

Gaba-fig-4-jpg.jpg (Gaba Fig 4 Jpg)

A scatter plot showing the percentage difference in response versus daily dose (mg) for Gabapentin. Data points represent results from three different studies labeled as Study a, Study b, and Study c, plotted across doses from 600 mg to 1800 mg.*

FDA Label Image

Gaba-structure.jpg (Gaba Structure)

Chemical structure of gabapentin displaying a cyclohexane ring with attached amine (CH2NH2) and carboxymethyl (CH2CO2H) groups, representing the molecule's arrangement.*

FDA Label Image

71205-619-72 (Gabapentin 400mg 100 Jpg)

Label for Gabapentin 400 mg capsules, 120 count, labeled for prescription use only. Capsules are hard gelatin with a white opaque body and orange opaque cap, imprinted with G 58 in black ink. Manufactured by Granules India Limited, made in India, and packaged by Proficient Rx LP in Thousand Oaks, CA. Storage recommendation is 20°-25°C.*

FDA Label Image

Gabapentin-formula-jpg.jpg (Gabapentin Formula Jpg)

A mathematical formula for creatinine clearance (CLCr) calculation based on age (years), weight (kg), serum creatinine (mg/dL), and a correction factor for female patients (0.85). The formula is presented in a fraction format showing how to compute CLCr.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.